Scribble by IKS Health vs ScribeRyte AI (2026)
Both are AI products from companies whose original business was human medical scribes, and that inheritance is the most useful thing about them. Between them they articulate the automation against human review spectrum more clearly than the pure play vendors do, because for these companies the human tier is not a safety net bolted on, it is the business they came from. Scribble is the fuller articulation of that spectrum and sits inside a larger clinical services organization. ScribeRyte makes the same tiering explicit from a scribe services base. For a health system with service lines that cannot accept a draft only workflow, buying the spectrum from one vendor beats running an AI contract and a scribe contract in parallel. The question to put to both is what happens to your price and your service level as the automated tier takes more of the volume.
- The documentation suite spans the range from automation to human review, which lets an organization choose how much human involvement it is buying rather than accepting a fixed design.
- It comes from an organization whose existing business is clinical documentation at scale, so the operational muscle behind the software already exists.
- For a health system that cannot accept a draft only workflow in every service line, having the human tier available from the same vendor avoids running two contracts.
- It articulates the same automation against human review question from the other side, as the AI product of a human scribe services company, so the tiering is explicit rather than implied.
- For practices that already use scribe services, moving along that spectrum with the incumbent is a smaller change than adopting an unrelated platform.
- The human tier is not a fallback here, it is the business the company was built on, which changes what happens when the model cannot cope.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Scribble by IKS Health and ScribeRyte AI are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Scribble by IKS Health | ScribeRyte AI |
|---|---|---|
| Primary category | Ambient Scribes | Ambient Scribes |
| Founded | Not recorded | 2016 |
| Headquarters | Navi Mumbai, Maharashtra, India | Woburn, Massachusetts, United States |
| Website | ikshealth.com | scribeemr.com |
Side by Side
Select any grade to read the note behind it.
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
Scribble by IKS Health
-
Product / capability
IKS Health launched Scribble Select, a new feature within the Scribble Suite that allows clinicians to choose between AI-only documentation, AI with human validation, or fully clinician-reviewed notes for each visit.
Source
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
Scribble is the clinical documentation suite from IKS Health. Five tiers span the range: Scribble Now is fully automated, producing a note within about two minutes of the encounter ending; Scribble Swift adds trained scribe validation and returns problem based charting within an hour or two; Scribble Pro adds clinician level review with medications, problem lists and orders reconciled to eliminate hallucinations, plus E&M coding, delivered within four hours; Scribble Transcribe is ASR with human editing; and Scribble Live provides dedicated virtual scribes covering pre charting, live documentation and inbox management.
Source: AI Health Index, August 2026
ScribeRyte AI is the ambient documentation product of ScribeEMR, a human medical scribe services company, and it sells as three AI tiers.
Source: AI Health Index, August 2026
Questions buyers ask
How are Scribble by IKS Health and ScribeRyte AI priced and sold?
For Scribble by IKS Health, enterprise sold to health systems and physician groups.
With ScribeRyte AI, the vendor's own pricing page names a 7 day free trial. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
How do Scribble by IKS Health and ScribeRyte AI handle patient data?
In Scribble by IKS Health's case, one specific engineered control works against that: in the virtual scribing tier, scribes never access video during telehealth encounters, which is a designed restriction on what a human reviewer can see rather than a policy promise.
For ScribeRyte AI, the vendor states that human scribe corrections are captured as track changes and fed back to train them. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
How much do Scribble by IKS Health and ScribeRyte AI leave to the clinician?
Rather than fixing the level of human oversight at contract, Scribble builds an escalation path into the workflow, so a clinician selects the level of support per encounter based on complexity, routing a simple visit to full automation and a complex or high risk one up the chain without leaving the product.
In ScribeRyte AI's case, the vendor's own material states this both ways. A ScribeEMR article says ScribeRyte AI routes every AI drafted note through trained medical scribes, while the same article and the Instant page describe Instant as fully automated. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Ambient Scribes page.
Both vendors come from human scribe services and the same question applies to each: what happens to the humans, and to your service level, as the automated tier improves. Ask both for the current mix of fully automated against human reviewed notes across their book, and what a shift in that mix does to your price. Neither publishes an accuracy figure, a model card or an evaluation methodology, and this comparison cannot speak to note quality on either side. Neither publishes a rate card, and pricing that spans a human tier and an automated tier is not comparable to a per clinician subscription without knowing the mix.